Recent Research from Department of Pharmacology Highlight Findings in Tetrahydrocannabinol.

Recent research from the Department of Pharmacology in Belo Horizonte, Brazil, highlights the potential of cannabidiol (CBD) to treat anxiety and epilepsy. Unlike delta-9-tetrahydrocannabinol (THC), CBD does not have psychotomimetic effects. The study found that CBD has anti-inflammatory properties and can be used to treat certain types of inflammatory and neuropathic pain. The research concluded that CBD induces systemic analgesia through the activation of the PI3K gamma/NO/KATP signaling pathway in neuropathic mice. [Extracted from the article]